Avotaciclib Uses, Dosage, Side Effects and more
Avotaciclib is under investigation in clinical trial NCT03579836 (Evaluation of Safety and Efficacy in BEY1107 in Monotherapy Gemcitabine Combination in Patient With Pancreatic Cancer).
| Trade Name | Avotaciclib |
| Generic | Avotaciclib |
| Avotaciclib Other Names | 2,6-bis(2-aminopyrimidin-4-yl)pyridin-3-ol, Avotaciclib |
| Type | |
| Formula | C13H11N7O |
| Weight | Average: 281.279 Monoisotopic: 281.102508002 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
